The Ras/Raf/MEK/Extracellular Signal-Regulated Kinase Pathway Induces Autocrine-Paracrine Growth Inhibition via the Leukemia Inhibitory Factor/JAK/STAT Pathway

REFERENCES

• Aubert, J., S. Dessolin, N. Belmonte, M. Li, F. R. McKenzie, L. Staccini, P. Villageois, B. Barhanin, A. Vernallis, A. G. Smith, G. Ailhaud, and C. Dani. 1999. Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. J. Biol. Chem. 274: 24965–24972.
   PubMed Web of Science ®Google Scholar
• Auernhammer, C. J., V. Chesnokova, and S. Melmed. 1998. Leukemia inhibitory factor modulates interleukin-1Â-induced activation of the hypothalamo-pituitary-adrenal axis. Endocrinology 139: 2201–2208.
   PubMedGoogle Scholar
• Auernhammer, C. J., and S. Melmed. 2000. Leukemia inhibitory factor-neuroimmune modulater of endocrine function. Endocr. Rev. 21: 313–345.
   PubMed Web of Science ®Google Scholar
• Blalock, W. L., P. W. Moye, F. Chang, M. Pearce, L. S. Steelman, M. McMahon, and J. A. McCubrey. 2000. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells. Leukemia 14: 1080–1096.
   PubMedGoogle Scholar
• Blalock, W. L., M. Pearce, F. Chang, J. T. Lee, S. C. Pohnert, C. Burrows, L. S. Steelman, R. A. Franklin, M. McMahon, and J. A. McCubrey. 2001. Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells. Leukemia 15: 794–807.
   PubMedGoogle Scholar
• Bousquet, C., and S. Melmed. 1999. Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling. J. Biol. Chem. 274: 10723–10730.
   PubMedGoogle Scholar
• Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. J. Darnell. 1999. Stat3 as an oncogene. Cell 98: 295–303.
   PubMed Web of Science ®Google Scholar
• Carlson, C. D., and R. P. Hart. 1996. Activation of acidic sphingomyelinase and protein kinase C zeta is required for IL-1 induction of LIF mRNA in a Schwann cell line. Glia 18: 49–58.
   PubMedGoogle Scholar
• Carson, E. B., M. McMahon, S. B. Baylin, and B. D. Nelkin. 1995. Ret gene silencing is associated with Raf-1 induced medullary thyroid carcinoma cell differentiation. Cancer Res. 55: 2048–2052.
   PubMed Web of Science ®Google Scholar
• Carson-Walter, E. B., D. P. Smith, B. A. Ponder, S. B. Baylin, and B. D. Nelkin. 1998. Post-transcriptional silencing of RET occurs, but is not required, during raf-1 mediated differentiation of medullary thyroid carcinoma cells. Oncogene 17: 367–376.
   PubMedGoogle Scholar
• Fanton, C. P., M. McMahon, and R. O. Pieper. 2001. Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation. J. Biol. Chem. 276: 18871–18877.
   PubMedGoogle Scholar
• Franza, B. R. J., K. Maruyama, J. I. Garrels, and H. E. Ruley. 1986. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell 44: 409–418.
   PubMedGoogle Scholar
• Garcia, R., C. L. Yu, A. Hudnall, R. Catlett, K. L. Nelson, T. Smithgall, D. J. Fujita, S. P. Ethier, and R. Jove. 1997. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell. Growth Differ. 8: 1267–1276.
   PubMedGoogle Scholar
• Gearing, D. P., N. M. Gough, J. A. King, D. J. Hilton, N. A. Nicola, R. J. Simpson, E. C. Nice, A. Kelso, and D. Metcalf. 1987. Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor (LIF). EMBO J. 6: 3995–4002.
   PubMed Web of Science ®Google Scholar
• Groth, A., J. D. Weber, B. M. Willumsen, C. J. Sherr, and M. F. Roussel. 2000. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J. Biol. Chem. 275: 27473–27480.
   PubMedGoogle Scholar
• Hahn, W. C., C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks, and R. A. Weinberg. 1999. Creation of human tumour cells with defined genetic elements. Nature 400: 464–468.
   PubMed Web of Science ®Google Scholar
• He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95: 2509–2514.
   PubMed Web of Science ®Google Scholar
• Huwiler, A., J. Brunner, R. Hummel, M. Vervoordeldonk, S. Stabel, H. van den Bosch, and J. Pfeilschifter. 1996. Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc. Natl. Acad. Sci. USA 93: 6959–6963.
   PubMed Web of Science ®Google Scholar
• Kamohara, H., K. Sakamoto, T. Ishiko, Y. Masuda, T. Abe, and M. Ogawa. 1997. Leukemia inhibitory factor induces apoptosis and proliferation of human carcinoma cells through different oncogene pathways. Int. J. Cancer 72: 687–695.
   PubMedGoogle Scholar
• Klesse, L. J., K. A. Meyers, C. J. Marshall, and L. F. Parada. 1999. Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells. Oncogene 18: 2055–2068.
   PubMedGoogle Scholar
• Kotanides, H., M. Moczygemba, M. F. White, and N. C. Reich. 1995. Characterization of the interleukin-4 nuclear activated factor/STAT and its activation independent of the insulin receptor substrate proteins. J. Biol. Chem. 270: 19481–19486.
   PubMedGoogle Scholar
• Lehmann, K., E. Janda, C. E. Pierreux, M. Rytomaa, A. Schulze, M. McMahon, C. S. Hill, H. Beug, and J. Downward. 2000. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14: 2610–2622.
   PubMed Web of Science ®Google Scholar
• Lloyd, A. C., F. Obermuller, S. Staddon, C. F. Barth, M. McMahon, and H. Land. 1997. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11: 663–677.
   PubMedGoogle Scholar
• Lotem, J., and L. Sachs. 1982. Mechanisms that uncouple growth and differentiation in myeloid leukemia cells: restoration of requirement for normal growth-inducing protein without restoring induction of differentiation-inducing protein. Proc. Natl. Acad. Sci. USA 79: 4347–4351.
   PubMed Web of Science ®Google Scholar
• Lu, C., and R. S. Kerbel. 1993. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol. 120: 1281–1288.
   PubMed Web of Science ®Google Scholar
• Malumbres, M., I. Perez De Castro, M. I. Hernandez, M. Jimenez, T. Corral, and A. Pellicer. 2000. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Mol. Cell. Biol. 20: 2915–2925.
   PubMedGoogle Scholar
• McCarthy, S. A., M. L. Samuels, C. A. Pritchard, J. A. Abraham, and M. McMahon. 1995. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 9: 1953–1964.
   PubMed Web of Science ®Google Scholar
• McCormick, F. 1998. Signal transduction. Why Ras needs Rho. Nature 394: 220–221.
   PubMedGoogle Scholar
• McMahon, M., and D. Woods. 2001. Regulation of the p53 pathway by Ras, the plot thickens. Biochim. Biophys. Acta 1471: M63–M71.
   PubMedGoogle Scholar
• Nagamoto-Combs, K., S. A. Vaccariello, and R. E. Zigmond. 1999. The levels of leukemia inhibitory factor mRNA in a Schwann cell line are regulated by multiple second messenger pathways. J. Neurochem. 72: 1871–1881.
   PubMedGoogle Scholar
• Nakagawa, T., M. Mabry, A. de Bustros, J. N. Ihle, B. D. Nelkin, and S. B. Baylin. 1987. Introduction of v-H-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. Proc. Natl. Acad. Sci. USA 84: 5923–5927.
   PubMed Web of Science ®Google Scholar
• Newbold, R. F., and R. W. Overell. 1983. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature 304: 648–651.
   PubMed Web of Science ®Google Scholar
• Niculescu, A. B., X. Chen, M. Smeets, L. Hengst, C. Prives, and S. I. Reed. 1998. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18: 629–643.
   PubMed Web of Science ®Google Scholar
• Ning, Z. Q., J. Li, and R. J. Arceci. 2001. Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells. Blood 97: 3559–3567.
   PubMed Web of Science ®Google Scholar
• Oh, H., Y. Fujio, K. Kunisada, H. Hirota, H. Matsui, T. Kishimoto, and K. Yamauchi-Takihara. 1998. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes. J. Biol. Chem. 273: 9703–9710.
   PubMed Web of Science ®Google Scholar
• Olsen, C. L., B. Gardie, P. Yaswen, and M. R. Stampfer. 2002. Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion. Oncogene 21: 6328–6339.
   PubMedGoogle Scholar
• Park, B. J., J. I. Park, D. S. Byun, J. H. Park, and S. G. Chi. 2000. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. Cancer Res. 60: 3031–3038.
   PubMed Web of Science ®Google Scholar
• Ravi, R. K., M. McMahon, Z. Yangang, J. R. Williams, L. E. Dillehay, B. D. Nelkin, and M. Mabry. 1999. Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells. J. Cell Biochem. 72: 458–469.
   PubMed Web of Science ®Google Scholar
• Ravi, R. K., A. Thiagalingam, E. Weber, M. McMahon, B. D. Nelkin, and M. Mabry. 1999. Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small cell lung cancer cells. Am. J. Respir. Cell Mol. Biol. 20: 543–549.
   PubMedGoogle Scholar
• Ravi, R. K., E. Weber, M. McMahon, J. R. Williams, S. Baylin, A. Mal, M. L. Harter, L. E. Dillehay, P. P. Claudio, A. Giordano, B. D. Nelkin, and M. Mabry. 1998. Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J. Clin. Investig. 101: 153–159.
   PubMed Web of Science ®Google Scholar
• Ridley, A. J., H. F. Paterson, M. Noble, and H. Land. 1988. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J. 7: 1635–1645.
   PubMedGoogle Scholar
• Roper, E., W. Weinberg, F. M. Watt, and H. Land. 2001. p19 ARF -independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO Rep. 2: 145–150.
   PubMed Web of Science ®Google Scholar
• Samuels, M. L., M. J. Weber, J. M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 kinase. Mol. Cell. Biol. 13: 6241–6252.
   PubMedGoogle Scholar
• Schiemann, W. P., and N. M. Nathanson. 1994. Involvement of protein kinase C during activation of the mitogen-activated protein kinase cascade by leukemia inhibitory factor. Evidence for participation of multiple signaling pathways. J. Biol. Chem. 269: 6376–6382.
   PubMed Web of Science ®Google Scholar
• Schulze, A., K. Lehmann, H. B. Jefferies, M. McMahon, and J. Downward. 2001. Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev. 15: 981–994.
   PubMed Web of Science ®Google Scholar
• Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593–602.
   PubMed Web of Science ®Google Scholar
• Sewing, A., B. Wiseman, A. C. Lloyd, and H. Land. 1997. High-intensity Raf signal causes cell cycle arrest mediated by p21cip1. Mol. Cell. Biol. 17: 5588–5597.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 2001. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell. Biol. 2: 731–737.
   PubMed Web of Science ®Google Scholar
• Shirasawa, S., M. Furuse, N. Yokoyama, and T. Sasazuki. 1993. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260: 85–88.
   PubMed Web of Science ®Google Scholar
• Spiotto, M. T., and T. D. Chung. 2000. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP. Prostate 42: 88–98.
   PubMedGoogle Scholar
• Spiotto, M. T., and T. D. Chung. 2000. STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells. Prostate 42: 186–195.
   PubMed Web of Science ®Google Scholar
• Stephens, J. M., S. J. Lumpkin, and J. B. Fishman. 1998. Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes. J. Biol. Chem. 273: 31408–31416.
   PubMedGoogle Scholar
• Taylor, W. R., and G. R. Stark. 2001. Regulation of the G2/M transition by p53. Oncogene 20: 1803–1815.
   PubMed Web of Science ®Google Scholar
• Vale, T., T. T. Ngo, M. A. White, and P. E. Lipsky. 2001. Raf-induced transformation requires an interleukin 1 autocrine loop. Cancer Res. 61: 602–607.
   PubMedGoogle Scholar
• Vindelov, L. L., I. J. Christensen, and N. I. Nissen. 1983. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323–327.
   PubMedGoogle Scholar
• Wang, X. W., and C. C. Harris. 1997. p53 tumor-suppressor gene: clues to molecular carcinogenesis. J. Cell Physiol. 173: 247–255.
   PubMed Web of Science ®Google Scholar
• Weber, J. D., J. R. Jeffers, J. E. Rehg, D. H. Randle, G. Lozano, M. F. Roussel, C. J. Sherr, and G. P. Zambetti. 2000. p53-independent functions of the p19ARF tumor suppressor. Genes Dev. 14: 2358–2365.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1997. The cat and mouse games that genes, viruses, and cells play. Cell 88: 573–575.
   PubMed Web of Science ®Google Scholar
• Wood, K. W., H. Qi, G. D'Arcangelo, R. C. Armstrong, T. M. Roberts, and S. Halegoua. 1993. The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction. Proc. Natl. Acad. Sci. USA 90: 5016–5020.
   PubMedGoogle Scholar
• Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and M. McMahon. 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21cip1. Mol. Cell. Biol. 17: 5598–5611.
   PubMed Web of Science ®Google Scholar
• Yamamoto-Yamaguchi, Y., M. Tomida, and M. Hozumi. 1992. Prolongation by differentiation-stimulating factor/leukemia inhibitory factor of the survival time of mice implanted with mouse myeloid leukemia cells. Leuk. Res. 16: 1025–1029.
   PubMed Web of Science ®Google Scholar
• Zhu, J., D. Woods, M. McMahon, and J. M. Bishop. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12: 2997–3007.
   PubMed Web of Science ®Google Scholar